Evidence map›Paper›PMID 40859015›Full record

ArticleEMBO reports2025

Structural obstruction to full DNA replication in terminally differentiated skeletal muscle cells.

Sara Zribi, Gladio Joel Giannitelli, Laura Bernardini, Federica Censi, Serena Camerini, Lucia Bertuccini, Francesca Iosi, Emilia Giannella, Massimo Sanchez, Elisa Consoli and 8 more

Abstract read
In one paragraph

Article in EMBO reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sara ZribiCore Facilities, Italian National Institute of Health, Rome, Italy.
Gladio Joel GiannitelliCore Facilities, Italian National Institute of Health, Rome, Italy.ORCID 0009-0008-0037-1991
Laura BernardiniMedical Genetics Division, Casa Sollievo della Sofferenza Foundation, San Giovanni Rotondo, FG, Rome, Italy.
Federica CensiNational Centre for Rare Diseases, Italian National Institute of Health, Rome, Italy.ORCID 0000-0001-6869-887X
Serena CameriniCore Facilities, Italian National Institute of Health, Rome, Italy.
Lucia BertucciniCore Facilities, Italian National Institute of Health, Rome, Italy.ORCID 0000-0002-4278-2376
Francesca IosiCore Facilities, Italian National Institute of Health, Rome, Italy.ORCID 0000-0002-5929-6833
Emilia GiannellaCore Facilities, Italian National Institute of Health, Rome, Italy.
Massimo SanchezCore Facilities, Italian National Institute of Health, Rome, Italy.
Elisa ConsoliCore Facilities, Italian National Institute of Health, Rome, Italy.ORCID 0000-0003-1741-3031
Andrea CasagrandeDepartment of Oncology and Molecular Medicine, Italian National Institute of Health, Rome, Italy.ORCID 0000-0003-3400-7609
Alessandra CenciCore Facilities, Italian National Institute of Health, Rome, Italy.ORCID 0000-0001-9648-8191
Giovanna FloridiaNational Centre for Rare Diseases, Italian National Institute of Health, Rome, Italy.ORCID 0000-0003-4187-8816
Antonio NovelliMedical Genetics Division, Casa Sollievo della Sofferenza Foundation, San Giovanni Rotondo, FG, Rome, Italy.ORCID 0000-0002-9037-4297
Alessandro GiulianiEnvironment and Health Department, Italian National Institute of Health, Rome, Italy.ORCID 0000-0002-4640-804X
Vincenzo CostanzoIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0002-2920-9508
Marco CrescenziCore Facilities, Italian National Institute of Health, Rome, Italy. marcosilvia86@alice.it.ORCID 0000-0003-0156-1494
Deborah PajalungaDepartment of Oncology and Molecular Medicine, Italian National Institute of Health, Rome, Italy.

Funding

Associazione Italiana per la Ricerca sul Cancro, Italy IG 2023-ID. 28725European Union - NextGeneration EU through the Italian Ministry of University and Research under PNRR - "Ecosistemi di Innovazione" ECS00000024 "Rome Technopole" (2022-2025)Istituto Superiore di Sanità, Italy project code ID ISS20-101042c64ab6Ministero della Salute, Italy PE-2011-02346905Ministero della Salute, Italy RF-2010-2310869
6 · The paper itself

Abstract

Terminal cell differentiation is often associated with permanent withdrawal from proliferation, termed the postmitotic state. Though widespread among vertebrates and determinant for their biology, the molecular underpinnings of this state are poorly understood. Postmitotic skeletal muscle myotubes can be induced to reenter the cell cycle; however, they generally die as a result of their inability to complete DNA replication. Here, we explore the causes of such incompetence. Genomic hybridization of newly synthesized DNA shows that the replicative failure does not concern specific genomic regions, but can stochastically affect any of them. Myoblast and myotube nuclei are incubated in replicative Xenopus egg extract, which provides a full DNA replication machinery. While myoblast nuclei attain complete DNA replication, those from myotubes, even in these conditions, duplicate less than half of their genomes, strongly indicating that the structure of myotube chromatin obstructs DNA replication. Furthermore, disassembling and disorganizing chromatin with a strong salt treatment does not modify the replicative differences between the two types of nuclei, suggesting that they are rooted in the core structure of chromatin.

Indexed as

Cell DifferentiationDNA ReplicationMuscle Fibers, SkeletalMuscle, SkeletalAnimalsCell NucleusChromatinMyoblastsChromatinCell CycleChromatinHistonesTerminal DifferentiationXenopus

Identifiers

PMID40859015
PMCPMC12508123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.